Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[PFE](/topic/pfe)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:pfe/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/pfe/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -X%  
**1 Month**: XX% -X%  
**6 Months**: XX% +12%  
**1 Year**: XX% +13%  
**1-Year High**: XX% on 2025-07-17  
**1-Year Low**: XX% on 2025-07-29  

**Most Supportive Themes**
- **Obesity Drug Market:** (38%) Pfizer's acquisition of Metsera for its obesity drug pipeline is viewed positively.
- **Dividend and Value Opportunity:** (15%) Some investors see Pfizer as a potential high-yield opportunity.
  
**Most Critical Themes**
- **Metsera Acquisition Concerns:** (40%)  Some analysts and investors are skeptical of Pfizer's acquisition of Metsera.
- **Patent Cliff and Future Challenges:** (10%)  Concerns persist regarding Pfizer's ability to overcome upcoming patent expirations.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| Reddit  | XXXXX    | X%  | XXX     | X%  | XX       | X% |
| TikTok  | XXX      | X%  | XXXXXX  | XX% | XX       | X% |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |
| YouTube | XXXXX    | X%  | XXXXXX  | XX% | XXXXX    | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

PFE

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% -X%
6 Months: XX% +12%
1 Year: XX% +13%
1-Year High: XX% on 2025-07-17
1-Year Low: XX% on 2025-07-29

Most Supportive Themes

  • Obesity Drug Market: (38%) Pfizer's acquisition of Metsera for its obesity drug pipeline is viewed positively.
  • Dividend and Value Opportunity: (15%) Some investors see Pfizer as a potential high-yield opportunity.

Most Critical Themes

  • Metsera Acquisition Concerns: (40%) Some analysts and investors are skeptical of Pfizer's acquisition of Metsera.
  • Patent Cliff and Future Challenges: (10%) Concerns persist regarding Pfizer's ability to overcome upcoming patent expirations.

Network engagement breakdown:

Network Positive % Neutral % Negative %
Reddit XXXXX X% XXX X% XX X%
TikTok XXX X% XXXXXX XX% XX X%
X XXXXXX XX% XXXXXX XX% XXXXX X%
YouTube XXXXX X% XXXXXX XX% XXXXX X%
News X X% X X% X X%
Total XXXXXX XX% XXXXXX XX% XXXXX X%
PFE Sentiment
/topic/pfe/sentiment